Abstract Interleukin (IL)-1 is a proinflammatory cytokine with important roles in innate immunity, as well as in normal tissue homeostasis. Interestingly, recent studies have also shown IL-1 to function in the dynamics of the actin cytoskeleton and cell junctions. For example, treatment of different epithelia with IL-1a often results in the restructuring of the actin network and cell junctions, thereby leading to junction disassembly. In this review, we highlight new and interesting findings that show IL-1 to be a critical player of restructuring events in the seminiferous epithelium of the testis during spermatogenesis.
Introduction
Interleukin (IL)-1 is a potent proinflammatory cytokine capable of triggering multiple physiological processes such as activation of lymphocytes, induction of acute-phase hepatic proteins, infiltration of leukocytes at sites of infection, fever and anorexia [1, 2] , clearly indicating that this cytokine is critical for innate immune response. Since the characterization of the IL-1a and IL-1b sequences more than two decades ago [3, 4] , several new members have been added into the growing IL-1 family (e.g., IL-33 [5] , also known as IL-1F11), and they have also been demonstrated to have roles in inflammation and host defense. In contrast to IL-2, which is a product of lymphocytes, IL-1 family members are products of macrophages. Furthermore, misregulation of IL-1 is known to underlie the pathogenesis of a myriad of auto-inflammatory diseases that are treatable by IL-1 receptor blockade [1, 6] . For example, in patients with familial cold autoinflammatory syndrome, the administration of IL-1 receptor antagonist prevented the onset of acute inflammatory symptoms, which were triggered by cold exposure [7] . Notwithstanding the proinflammatory nature of IL-1, the a subtype of this cytokine also has normal physiological roles, and it is known to participate in the regulation of cell proliferation and differentiation [8, 9] , illustrating the breadth of IL-1 function. Interestingly, growing evidence has revealed that IL-1 signaling frequently targets the actin cytoskeleton during both inflammatory conditions and normal tissue homeostasis [10, 11] . In this review article, we highlight the emerging role of IL-1 in the restructuring of cell junctions and the cytoskeleton in epithelia and other tissues. In particular, we discuss the activities of IL-1a in the seminiferous epithelium, where it coordinates junction restructuring events at the blood-testis barrier (BTB) and Sertoli-germ cell adhesion throughout the seminiferous epithelial cycle of spermatogenesis [12, 13] .
Overview of IL-1 properties and signaling
IL-1 is the founding member of the IL-1 family of ligands, which is currently constituted by 11 members including both agonist molecules that are capable of activating receptor-mediated signaling (e.g., IL-1a, IL-1b, IL-18 and IL-33) and antagonist molecules (e.g., IL-1 receptor antagonist ) [1] . In conventional terms, IL-1a and IL-1b are collectively referred to as IL-1, which was initially reported to be a fever-inducing proinflammatory substance but later shown to consist of two distinct gene products [14] . These two IL-1 subtypes, together with their physiological inhibitor IL-1Ra, are perhaps the most well studied members of the IL-1 family. In this section, we discuss the general properties and the signaling/nonsignaling roles of IL-1. For additional background information, interested readers are referred to two recent reviews [1, 15] .
The biogenesis of IL-1 IL-1a and IL-1b are both expressed as 31-kDa precursors (proIL-1), each of which is encoded by a distinct gene and are the products of macrophages [16] . While in vitro experiments using recombinant mature proteins have shown IL-1a and IL-1b to exhibit similar biological effects, in vivo, however, they have distinct physiological roles and regulatory mechanisms. For instance, IL-1b must be processed into a mature protein for optimal activity, but its counterpart has activity as both a mature and a precursor protein which is partly due to proIL-1a's ability to bind IL-1 receptor type I (IL-1RI) [17] . These intracellular precursors are cleaved by cysteine proteases into a propiece and a mature 17-kDa protein. Specifically, proIL-1a is processed by calpain [18] , whereas proIL-1b is processed by caspase-1 (formerly known as IL-1b-converting enzyme) [19] . Indeed, mice lacking caspase-1 are defective in the maturation of proIL-1b and IL-18 [20, 21] .
IL-1 secretion does not adhere to the classical endoplasmic reticulum-Golgi route given that both IL-1 subtypes lack a signal peptide [22] . Instead, IL-1b maturation and secretion require the assembly of large (i.e., *700 kDa) multi-protein complexes known as inflammasomes [23, 24] . In essence, the inflammasome is a molecular scaffold that directs caspase-1 activation for the cleavage of proIL-1b. A similar mechanism exists for IL-18 as well [24] . The assembly and activation of inflammasomes can be triggered by infection, stress, reactive oxygen species and cell disruption; and their activation has been linked to such diseases as type II diabetes and gout [24, 25] . Several prototypical inflammasomes are known to exist, and each of them contains a distinct NOD-like receptor (NLR) such as NALP1 (NACHT, LRR and PYDcontaining protein 1) [24, 26] . NLR proteins are intracellular pathogen sensors that facilitate the assembly of other inflammasome components, including the adaptor protein ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain), the effector procaspase-1, as well as other inflammatory caspases (e.g., caspase-5 and -11) [24, 26, 27] . In addition to the conformational change in procaspase-1 that is induced by its recruitment to inflammasomes, the activation of procaspase-1 requires a secondary stimulus that produces ionic perturbations in cells [26] . One example of such a stimulus is the activation of P2X 7 from cells (e.g., macrophages), which in turn promotes caspase-1 activation, resulting in proIL-1b cleavage [25, 30] . In fact, several findings have indicated that stimulation of the P2X 7 receptor can activate c-Jun N-terminal kinases (JNK) 1 and 2, extracellular signal-regulated kinases (ERK) 1 and 2, and p38 mitogen-activated protein kinase (MAPK) [31] [32] [33] . Taken together, IL-1b maturation is a tightly regulated process with complex underlying signaling pathways.
The release of mature IL-1b from cells is mediated by at least two different secretory pathways. First, the exocytosis of IL-1b characterized by Andrei et al. [34] involves the loading of proIL-1b and procaspase-1 into secretory lysosomes, which eventually results in the externalization of mature IL-1b and other lysosomal contents in a phospholipase-dependent manner [34] . Alternatively, IL-1b is secreted by the budding of small plasma membrane blebs (i.e., microvesicles) [35] . This has been visualized by the live imaging of activated monocytes, in which bioactive IL-1b-containing membrane blebs were rapidly shed from the plasma membrane shortly after exposure to 3 0 -O-(4-benzoylbenzoyl) ATP (BzATP), a synthetic P2X 7 receptor agonist [35] . On a final note, unlike IL-1b, which is largely secreted by activated immune cells (e.g., monocytes, dendritic cells and neutrophils), IL-1a is hardly ever detected in sera or in bodily fluids during inflammation, and its occasional presence may simply be due to IL-1a being released from dying cells [36] . Instead, IL-1a is generally believed to function intracellularly and/or at the cell surface where a membrane-bound myristoylated form of proIL-1a has been reported to exist [37] . However, the testis appears to be an exception since secreted IL-1a can be detected in the fluids within this organ such as in seminiferous tubular and rete testis fluids under normal circumstances [38] , which will be discussed later.
Receptor-mediated IL-1 signaling There are two types of receptors that bind IL-1, namely IL-1 receptor type I and type II (IL-1RI and IL-1RII, respectively) [1] . Of these, signaling is mediated exclusively by IL-1RI, a member of the interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) superfamily [39] (Fig. 1) , whereas IL-1RII is a prototypical decoy receptor with regulatory functions [40, 41] . For both receptors, the IL-1/ IL-1R complex recruits a co-receptor known as IL-1 receptor accessory protein (IL-1RAcP) [42, 43] , thereby resulting in the formation of a heterodimeric receptor complex that is essential for IL-1RI-mediated signal transduction (Fig. 1) . Signaling is initiated by the juxtaposition of Toll-IL-1 receptor (TIR) domains present within the cytoplasmic tails of IL-1RI and IL-1RAcP [44] . Basically, these events lead to the recruitment of myeloid differentiation primary response gene 88 (MyD88), an adaptor protein that in turn recruits IL-1 receptor associated kinases (IRAKs) [45, 46] . Four IRAKs are known to exist, IRAKs-1 through -4 [47] [48] [49] . Of these, IRAK-3 (or IRAK-M) lacks intrinsic kinase activity and is a negative regulator of TLR signaling, whereas IRAK-4 is indispensable for IL-1R/TLR signaling [46] . Within the IL-1RI signaling complex, IRAK-4 kinase activity promotes the phosphorylation and activation of IRAK-1, which in turn recruits tumor necrosis factor receptor-associated factor (Traf)-6 [39, 50] . The subsequent dissociation of these kinases from the receptor complex and the recruitment of downstream signaling molecules, ultimately result in the activation of nuclear factor-jB (NF-jB) and MAPK pathways [39, 50, 51] (Fig. 1) . IL-1RII, on the other hand, does not possess a TIR domain, and the resulting heterodimeric receptor complex is non-signaling [44] . Hence, its sequestration of IL-1 and the co-receptor IL-1RAcP negatively regulates IL-1RI-mediated signaling. Adding to the intricacy, IL-1RII was also found to be required for proIL-1a activity in the nucleus [52] , illustrating its involvement in a wide range of biological processes within cells.
Non-receptor-mediated proIL-1a signaling
There is evidence to suggest that intracellular IL-1a, especially nuclear-localized proIL-1a, also participates in signaling events that are beyond those of the classical IL-1RI-mediated pathway. First, proIL-1a exhibited biological Biology of IL-1 in the testis 489 activity that was independent of IL-1 signaling mediated by cell surface receptors [53] . In endothelial cells for instance, over-expression of a proIL-1a fusion protein inhibited cell proliferation, and this effect was insensitive to the addition of exogenous IL-1Ra, which would have blocked cell surface receptors [53] . Second, proIL-1a (but not proIL-1b) can be actively imported into the nucleus due to the presence of a nuclear localization sequence residing in the precursor domain, unlike mature IL-1a, which is largely restricted to the cytoplasm [54] . Nuclear translocation of proIL-1a is regulated by a number of different proteins, including Ras-related nuclear protein (Ran; a small GTPase) [55, 56] and HS1-associated protein X-1 (HAX-1, a multi-functional protein with roles in apoptosis and cell migration [57] that binds to IL-1a [58] ). Third, nuclearlocalized proIL-1a participates in transcriptional regulation. For instance, the transcription of collagenase was up-regulated in endothelial cells that over-expressed proIL1a fusion protein [53] . On a final note, misregulation of proIL-1a nuclear translocation is linked to the pathogenesis of diseases such as systemic sclerosis (SSc) [52] . Skin fibroblasts obtained from SSc patients showed an aberrant accumulation of proIL-1a in the nucleus [59] , which was suppressed by the knockdown of HAX-1 [52] . Equally important, this blockage of proIL-1a nuclear entry was also accompanied by the relief of certain SSc phenotypes (e.g., excessive IL-6 production) [52] , illustrating the significance of tightly regulating proIL-1a localization.
Mechanisms of cytoskeletal and cell junctional remodeling by IL-1 IL-1 stimulation can result in profound changes in cellular behavior, which oftentimes involves remodeling of the cytoskeleton and changes in cell-cell adhesion. For instance, IL-1 is known to induce actin stress fiber formation in different cell types [60, 61] , and to increase tight junction (TJ) permeability in the intestinal epithelium [62] and in the blood-brain barrier [63] . IL-1 is also involved in the noninflammatory-related restructuring of cell junctions, which occurs during normal tissue homeostasis. For instance, IL-1a was recently reported to affect the permeability of the blood-testis barrier (BTB) during spermatogenesis [12, 13] , which we will discuss in detail later. In the following two sections, we highlight signaling events that underlie IL-1-induced cytoskeletal and cell junctional remodeling.
Regulation of cytoskeletal and junctional dynamics through Rho GTPases
The small GTPases RhoA and Rac1 are likely to be effectors in IL-1 signaling because a fusion protein of IL-1RI co-immunoprecipitated with RhoA and Rac1 in HeLa cell extracts [64] . These proteins are members of the Rho GTPase family (e.g., RhoA-C, Rac1-3 and Cdc42), which are molecular switches best known for their role in regulating the actin cytoskeleton, as well as cell polarity and vesicular transport [65, 66] . Two major types of Rho effectors are crucial for the induction of actin polymerization, namely diaphanous-related formins (DRFs) and WASP (Wiskott-Aldrich syndrome protein)/WAVE (WASP-family verprolin-homologous protein) [65, 67] . While both DRFs and WASP/WAVE proteins promote the nucleation of actin filaments, the resulting structures have distinct conformations. DRFs facilitate the polymerization of unbranched actin filaments upon activation by RhoA, B or C; whereas WASP/WAVE proteins, effectors of Cdc42 and Rac1 respectively, favor the formation of the dendritic actin network via the activity of the Arp (actin-related protein) 2/3 complex [65, 68, 69] . Furthermore, Rho is capable of activating another class of effectors that indirectly encourages actin polymerization, namely p160 Rhoassociated coiled-coil-containing protein kinase (ROCK). This serine/threonine kinase phosphorylates and activates LIM kinase, which in turn targets cofilin. As a result, phosphorylated cofilin is incapable of severing and depolymerizing actin [65, 68, 69] , thereby promoting actin polymerization. RhoA and Rac1 have been reported to participate in IL-1 signaling. For instance, Rac1 activity appears to be required for the formation of lamellipodia in SH-SY5Y neuroblastoma cells that were grown on collagen and treated with IL-1b [70] . This Rac1-dependent effect may be mediated through the activation of WAVE proteins, which in turn activate the Arp2/3 complex for the nucleation of actin branches, thereby forming a dendritic network characteristic of lamellipodia [67, 68] . Nevertheless, additional studies are needed to substantiate the role of Rac1 as an IL-1 effector. In the case of Rho, evidence shows an association of Rho activity with IL-1 signaling particularly at focal adhesions. As mentioned previously, IL-1RI physically interacts with RhoA [64] , a crucial regulator of focal adhesion assembly [71] . IL-1b was also found to be clustered at cell-matrix adhesion sites that resembled focal adhesions [72] , which implies that focal adhesions are key sites that harbor IL-1 receptors. Moreover, a number of studies indicate that IL-1 signaling relies on integrins and cell-matrix adhesion because the effects of IL-1 were abrogated after integrin-blocking antibodies were used or after cells were plated on non-integrin substrates [73] [74] [75] . Finally, and most importantly, IL-1-induced reorganization of the actin cytoskeleton into stress fibers is dependent on Rho activity since this phenotype is blocked by inhibitors of Rho (e.g., C3 transferase) and its effector ROCK (e.g., Y27632) [60, 74, 76] . In these studies, treatment with IL-1 (including both a and b subtypes) induced the formation of cytosolic stress fibers as visualized by phalloidin staining in cultured endothelial cell monolayers [60, 74] and isolated chondrocytes [76] , and this effect was suppressed by pre-treating cells with Rho/ROCK inhibitors. Downstream of Rho-ROCK signaling, LIM kinase-mediated inactivation of cofilin, an actin severing and depolymerizing protein, would therefore encourage actin polymerization during stress fiber assembly [67, 68] .
In summary, these results demonstrate that Rho activity participates in IL-1-induced stress fiber formation, which is important for focal adhesion and cell junction dynamics (Fig. 1) . By definition, stress fibers are contractile structures comprised of actin filaments, crosslinking proteins and myosin II motors. They attach to focal adhesions, and their assembly is generally under the regulation of Rho [71, 77] . Moreover, this type of actin-based structure is especially prominent in fibroblasts in vitro where it functions in cell-matrix adhesion and in the transmission of tensile forces during cell movement. The formation of stress fibers in different epithelia and endothelia may also be connected to cell junctional integrity. For example, blocking Rho activity during treatment of endothelial cells with IL-1 not only prohibits the formation of stress fibers; it also prohibits TJ disruption and paracellular gap formation [74] . In another study, IL-1b was found to up-regulate transforming growth factor (TGF)-b in a Rho-dependent manner [74] . Not surprisingly, this cytokine is also known to adversely affect TJ integrity [78, 79] , suggesting that IL-1 may be working with other cytokines such as TGF-b and TNF to facilitate junction restructuring.
Regulation of cytoskeletal and junctional dynamics through nuclear factor-jB It is well known that IL-1 stimulation induces the activation of nuclear factor-jB (NF-jB) (Fig. 1) , a major mediator of IL-1-induced genomic effects and whose misregulation is known to participate in the pathogenesis of many diseases such as cancer and diabetes [80, 81] . NF-jB, a transcription factor comprised of proteins from the NF-jB/Rel family, plays a key role during inflammation via the transcriptional regulation of proinflammatory genes such as cytokines, adhesion molecules and matrix metalloproteases [82] . NF-jB is normally maintained in an inactive state within the cytoplasm of unstimulated or resting cells where it is sequestered by inhibitors (i.e., IjBs or the unprocessed forms of NF-jB1 and NF-jB2), until signaling is induced by stress factors such as IL-1, tumor necrosis factor (TNF)-a or lipopolysaccharides (LPS) [82, 83] . In brief, the canonical NF-jB pathway is mediated through the activation of the IjB kinase (IKK) complex, which in turn phosphorylates the inhibitor IjBa. The resulting ubiquitination and degradation of IjBa leads to a transient increase in unbound NF-jB molecules that are free to translocate into the nucleus, thereby functioning in transcriptional regulation [82, 83] (Fig. 1 ).
Several reports have described the role of NF-jB in IL-1b-induced modulation of intestinal epithelial cell junctions. For example, treatment of Caco-2 cells with IL-1b is known to increase the permeability of TJs [62] , and this effect is mediated by the canonical NF-jB pathway, which involves upstream regulation by MEKK-1 (MAP/Erk kinase kinase-1; a MAPK kinase kinase) [84] . These adverse effects of IL-1b on TJ function are accompanied by a decrease in the mRNA level of occludin [62] , but an increase in the protein level and kinase activity of myosin light chain kinase (MLCK) [85] . Moreover, these IL-1b-mediated effects can be abrogated following NF-jB inhibition/p65 knockdown [62, 85] , MEKK-1 knockdown [84] or MLCK inhibition/knockdown [85] , confirming the specificity of these effects. Notably, the ability of IL-1 to stimulate MLCK expression illustrates its dual role in regulating actin stress fiber assembly (see previous section) and contractility. MLCK is a serine/threonine protein kinase that phosphorylates the regulatory light chain of myosin II and stimulates its activity in actomyosin contraction [86, 87] , thereby generating force during events such as cell migration. In epithelial and endothelial barriers, MLCK-induced contraction of the perijunctional actomyosin belt is also associated with weakened cell adhesion [87, 88] . Therefore, IL-1-induced barrier disruption is likely to be a combined effect involving changes in junctional protein expression, and the assembly and contraction of actomyosin structures, which are mediated through the activities of Rho and MLCK (Fig. 1) .
IL-1a as a regulator of normal tissue homeostasis
As discussed previously, IL-1 is a proinflammatory cytokine, and for this reason, many studies on IL-1 are set in the context of pathological inflammatory conditions such as acute lung injury [74] , osteoarthritis [76] and autoimmune thyroid disease [61] . Still, other studies have shown constitutive expression of IL-1a (but not IL-1b) in a number of tissues such as the skin and the endothelium, where it functions as an autocrine growth factor or in normal tissue homeostasis [1, 16] . The interplay of IL-1a with IL-1Ra regulates cell proliferation and differentiation in a number of different cell types. In skin fibroblasts and endothelial cells, for instance, the up-regulation of IL-1a production in aging cells is associated with growth arrest and senescence [8, 89] . Indeed, the inhibition of IL-1a by the use of antisense oligomers [8] or the addition of exogenous IL-1Ra
Biology of IL-1 in the testis 491 [90] extended the proliferative lifespan and enhanced the replicative capacity of endothelial cells. On the other hand, IL-1a influences keratinocytes in a different manner. Throughout keratinocyte maturation, the IL-1a level remains constant, whereas IL-1Ra accumulates highly in large differentiated cells [9] . Moreover, IL-1a secreted by keratinocytes stimulates the production of growth factors (e.g., keratinocyte growth factor) in skin fibroblasts, which in turn support keratinocyte proliferation [91] . These two observations suggest that IL-1a signaling associates with the proliferation of keratinocytes, while its attenuation promotes cell differentiation instead. In addition to the regulation of keratinocyte growth, expression of IL-1a in the epidermis was found to be important for the restoration of permeability barrier function after acute barrier disruption [92, 93] . Taken collectively, these findings illustrate important physiological roles for IL-1a in the regulation of cell turnover and in promoting tissue repair, thereby maintaining normal tissue function. To further support IL-1a's role in homeostasis, we have recently demonstrated IL-1a to be an important regulator of cytoskeletal and cell junctional dynamics in the seminiferous epithelium of the mammalian testis [12, 13] . In the following sections, we focus primarily on the non-inflammatory related functions of IL-1a during spermatogenesis.
Role of IL-1a in spermatogenesis
Introduction to spermatogenesis
In the seminiferous epithelium of the adult mammalian testis, spermatogenesis is the process in which germ cells undergo cell division, differentiation and morphogenesis to become spermatozoa [94] . These events take place continuously throughout the seminiferous epithelial cycle, which is divided into a defined number of stages. In the rat for instance, the seminiferous epithelial cycle consists of 14 stages, and each stage is characterized by a unique arrangement of specific germ cell types (i.e., spermatogonia, spermatocytes and spermatids) in the epithelium.
(Please refer to recent reviews [95, 96] for detailed morphological characteristics and important cellular events that occur during the rat seminiferous epithelial cycle). Throughout germ cell development, these cells are structurally and nutritionally supported by somatic epithelial cells known as Sertoli cells, which span the entire height of the seminiferous epithelium [97] . One of the most important roles ascribed to Sertoli cells is the formation of the BTB, which is constituted by coexisting TJs, ectoplasmic specializations (ESs, a testis-specific actin-based anchoring junction), desmosomes and gap junctions that are found basolaterally and near the basement membrane [95, 98, 99] .
The integrity of the BTB is critical for sequestering post-meiotic germ cells from the systemic circulation, and any compromise in its function may trigger an autoimmune response (and possibly subfertility or infertility) because antigens residing on the surfaces of meiotic germ cells would be seen as foreign by the host's immune system (i.e., immune tolerance develops well before mature spermatozoa). Still, the BTB must transiently restructure to allow the entry of spermatocytes into the adluminal compartment of the seminiferous epithelium for further development, and this event takes place during stages VIII to XI of the seminiferous epithelial cycle in the rat [100, 101] . Morphological observations from the late Lonnie Russell proposed that a ''new'' BTB assembles beneath spermatocytes while they migrate upwards and break through the gates, so to speak, of the ''old'' BTB that is situated above them [100] . In this way, the spermatogenic process and fertility can be maintained. Moreover, the movement of spermatocytes across the BTB also coincides with the release of spermatozoa (i.e., spermiation) at late stage VIII [102, 103] . These elaborate yet highly synchronized restructuring events, which also involve the cytoskeleton, are believed to be coordinated in large part by factors secreted by testicular cells (e.g., cytokines, androgens and estrogens) [104, 106] . In this regard, IL-1a is emerging as an important regulator of cell junctions and the cytoskeleton in the seminiferous epithelium.
The IL-1 system in the testis Cells of the adult mammalian testis constitutively express IL-1a [38, [107] [108] [109] and its antagonist IL-1Ra [110, 111] , as well as IL-1RI and IL-1RII [112] (Table 1 ). The identity of the protein exhibiting IL-1 bioactivity in the testis was confirmed to be the a subtype because its ability in promoting thymocyte proliferation was obliterated by IL-1a [38, 108] but not by IL-1b [108] antiserum. Furthermore, several immunoreactive IL-1a isoforms are known to exist in the testis with apparent molecular weights ranging from 17-45 kDa [38, 113] . Besides the 17-kDa mature and 31-kDa proIL-1a forms that were previously discussed, another variant of 24 kDa is known to be produced from an alternatively spliced transcript. While the function of this variant in the testis has yet to be determined, the 24-kDa form is also capable of promoting thymocyte proliferation, but unlike the other isoforms, it fails to inhibit human chorionic gonadotropin-driven steroidogenesis in Leydig cells (interstitial cells that produce testosterone when stimulated by luteinizing hormone) [113] . In contrast, IL-1b is absent and its transcripts are barely detectable in the testis under normal physiological conditions [38, 107, 114] .
Interestingly, these IL-1a isoforms are not only detected in testis extracts, but also in seminiferous tubule and interstitial fluids [38] . These findings are intriguing because IL-1a is rarely secreted [1] , and its occasional presence in bodily fluids is most likely due to dying cells releasing their cytoplasmic contents [36] . Moreover, when cultured in vitro, bioactive IL-1a is secreted by seminiferous tubules [115] and Sertoli cells [108] , but other testicular cell types (e.g., germ cells and interstitial cells) do not secrete it into the culture medium [108] even when immunoreactive IL-1a is detected in their lysates [109] (Table 1) . Even though Sertoli cells appear to be the major source of secreted IL-1a in the testis, germ cells play an equally important role because their loss from the seminiferous epithelium halted IL-1a production by Sertoli cells [107] , illustrating that germ cells regulate Sertoli cell production of IL-1a. To further support the role of IL-1a as a paracrine regulator, IL-1a showed a stage specific expression pattern in the seminiferous epithelium [107, 115, 116] . As detected by both ELISA and a bioactivity assay, IL-1a is highly expressed throughout the entire seminiferous epithelial cycle except at stage VII when its level is the lowest [107, 115, 116] . This is followed by an increase of more than threefold beginning at stage VIII, which may be the result of Sertoli cells phagocytosing residual bodies emanating from elongated spermatids [115, 117] .
Since this increase in IL-1a temporally coincides with both BTB restructuring and spermiation, which take place at stage VIII of the seminiferous epithelial cycle, the possible role of IL-1a in coordinating these events was explored in two recent studies [12, 13] . Results from these studies have illustrated IL-1a to regulate the remodeling of the cytoskeleton and cell junctions during spermatogenesis, which we will discuss in the following sections. Furthermore, numerous studies have demonstrated IL-1a to be a multi-functional regulator of spermatogenesis. First, IL-1a is a growth factor used by testicular cells, including immature Sertoli cells [118, 119] and spermatogonia [120] . For example, the lowest level of IL-1a expression during stage VII of the seminiferous epithelial cycle in the adult rat testis coincides with the lack of germ cell proliferation at this stage [107] . Second, IL-1a regulates the production of other cytokines and paracrine factors, as well as other cellular processes, in the testis. These include the production of IL-6 [115] and activin A (a member of the transforming growth factor [TGF]-b family) [121] in Sertoli cells, and the regulation of steroidogenesis in Leydig cells [122] [123] [124] .
Effects of IL-1a on cell adhesion in the seminiferous epithelium Two critical cellular events take place simultaneously at stage VIII of the seminiferous epithelial cycle, namely the restructuring of the BTB and the release of spermatozoa [103] [104] [105] . Thus, the increase in IL-1a at stage VIII is likely to facilitate these two events (Fig. 2) . The earliest findings to support this concept emerged from an in vivo study where intratesticular injection of recombinant IL-1a was shown to perturb both Sertoli-germ cell adhesion and BTB integrity [12] . Owing to the fact that IL-1a is normally present in the adult rat testis at the physiological level of *200 pM [116] , this study sought to unmask the phenotype of IL-1a signaling by treating testes with an acute dose of recombinant IL-1a (three doses each at *50 times the physiological level) [12] . This IL-1a treatment regimen resulted in severe germ cell loss from the seminiferous epithelium, and elongated spermatids from stage VII and VIII tubules were depleted before other germ cell types [12] , in a way resembling aberrant ''spermiation''. This indicates that a precise and tightly controlled level of IL-1a in the seminiferous tubule microenvironment is essential for maintaining Sertoli-germ cell adhesion. Equally important, the adverse effects of IL-1a on BTB restructuring were also investigated by an in vivo BTB integrity assay. In brief, a small fluorescent probe (i.e., inulin-FITC) was injected into the jugular vein of rats. Thereafter, the integrity of the BTB was assessed by its ability to block the diffusion of inulin-FITC from the systemic circulation, across the BTB and into the adluminal compartment of the seminiferous epithelium. In this case, inulin-FITC was able to penetrate the compromised BTB in IL-1a-treated testes [12] . Likewise, the organization of filamentous (F-) actin at the BTB and [38] mRNA [107] ; protein b secreted into culture media [108] mRNA and protein a in immature germ cells c [109] ; absent in culture media [108] protein a [38] ; absent in culture media [108] IL-1b low level of mRNA in intratubular cells; level undetectable in some cases [107, 114] mRNA [114] IL-1Ra mRNA and protein a [110] mRNA in round spermatids [111] mRNA [111] IL-1RI & IL-1RII mRNA [112] mRNA [112] mRNA in immature germ cells c from rodents but not from humans [112] mRNA [112] a Immunoreactive protein at sites of Sertoli-germ cell adhesion was adversely affected after IL-1a treatment. Specifically, there was a loss of actin filament bundles that constitute the ES when examined by electron microscopy [12] . While the increase in TJ permeability is reminiscent of the effects of IL-1 in other tissues [62, 74] , no obvious signs of stress fiber formation were noted in our study. Nevertheless, actin remodeling is likely to be a key factor in IL-1a-induced BTB disruption because no changes in the levels of BTB constituent proteins were noted, and this is in contrast to the effects of other cytokines in the testis such as TGF-b3 [125] and TNF-a [126] .
Mechanisms of IL-1a-induced remodeling of the Sertoli cell cytoskeleton and BTB Additional data to support the role of IL-1a in actin remodeling at the BTB were provided by a subsequent in vitro study that used polarized Sertoli cells having a functional TJ permeability barrier [13] . In line with the in vivo results just described, treatment of Sertoli cells with IL-1a led to F-actin disorganization and barrier disruption when assessed by fluorescence microscopy and transepithelial electrical resistance measurements, respectively [13] . Instead of uniformly distributed actin bundles, is believed to play a role in BTB restructuring and apical ES disassembly. IL-1 signaling (green arrows) may contribute to the (i) remodeling of actin bundles into a branched network by mislocalizing Eps8 and increasing Arp2/3 activity; (ii) disassembly and/or endocytosis of BTB junctional complexes, which possibly involves the p38 MAP kinase pathway; (iii) inhibition of BTB protein degradation; and (iv) disassembly of Sertoli-germ cell adhesion, which possibly involves the ERK pathway. These effects, together with testosterone, which is known to promote the recycling of BTB proteins, result in the simultaneous disassembly of the ''old'' BTB and the assembly of a ''new'' BTB. Thus, BTB integrity is maintained while preleptotene spermatocytes enter the adluminal compartment with spermiation occurring at the opposite end of the seminiferous epithelium IL-1a-treated cells showed haphazard clusters of F-actin and overgrown filaments, which appeared to stretch over to neighboring Sertoli cells [13] . These effects were mediated in part by two actin regulatory proteins previously shown to regulate the BTB and Sertoli-germ cell adhesion, namely epidermal growth factor receptor pathway substrate 8 (Eps8) [127] and actin-related protein (Arp) 3 [128] (Fig. 2) . Arp3 is a member of the Arp2/3 complex which is known to function as the major actin nucleation machinery during the formation of the branched actin network [129] , whereas Eps8 is a multi-functional actin regulator with barbed-end capping activity [130] . Eps8 also participates in actin bundling mediated by insulin receptor substrate p53 [131] , as well as in the activation of Rac, which is mediated by the GTP exchange factor Sos (son of sevenless)-1. Therefore, by associating with different protein complexes, Eps8 not only plays a role in the formation of actin bundles, but also in the branching of actin by virtue of its actin barbed-end capping activity and Rac activation.
The mislocalization of Eps8 in Sertoli cells following IL-1a treatment may very well explain the overgrowth of actin filaments and the loss of their bundle-like appearance [13] , observations which are comparable to those observed after Eps8 knockdown by RNAi [127] . Likewise, an increase in the Arp3 protein level may facilitate the formation of an actin network, as opposed to unbranched actin bundles [13] . The differential activity of these two actin regulators is also reflected by their contrasting expression patterns at the BTB in vivo prior to the onset of BTB restructuring at stage VIII. The highest level of Eps8 is detected at the BTB in earlier stages (i.e., V-VI), followed by a decrease until it is no longer detectable at stage VIII [127] . On the contrary, Arp3 peaks at the BTB precisely at stage VIII during BTB restructuring, which allows the transit of preleptotene spermatocytes [128] . Thus, considering the stage specific expression pattern of these two actin regulators, IL-1a may be coordinating the downregulation of Eps8 and the recruitment of Arp3 to the site of the BTB during stage VIII. In this way, the actin cytoskeleton can be remodeled from rigid bundles into more flexible branches to facilitate the restructuring of the BTB and the movement of preleptotene spermatocytes (Fig. 2) . Given these interesting results, additional studies are needed to confirm whether Eps8 and the Arp2/3 complex indeed mediate restructuring of the actin cytoskeleton in response to IL-1a. For example, can Eps8 overexpression rescue the defects in actin capping following IL-1a treatment? Furthermore, the participation of other actinregulating proteins such as Rho, which is known to mediate IL-1-induced actin remodeling, should also be investigated in the future.
In the context of the seminiferous epithelium in vivo, IL-1a-mediated regulation of Eps8 and Arp2/3 activity likely represents an important mechanism for ES disassembly. As described previously, the ES is a unique actinbased anchoring junction type found in Sertoli cells. By electron microscopy, the ES is typified by the presence of unipolar actin bundles sandwiched in between cisternae of the endoplasmic reticulum and the plasma membrane at the cell-cell interface [98, 99, 132, 133] . ESs found at the BTB (defined as basal ES) coexist with other junction types, and they mediate strong intercellular adhesion in the Sertoli cell epithelium. Likewise, analogous structures (i.e., apical ES) are found within Sertoli cells at the sites where elongating spermatids attach, serving as the sole anchoring device for post-step 8 spermatids until their release [134] . Removal of these strong adhesions is thus necessary for the impending restructuring of the BTB and release of spermatozoa during stage VIII. The gradual process of ES degeneration is associated with the remodeling of the characteristic actin bundles at the ES into a highly branched network [132, 133] . As such, this process likely involves the participation of Eps8 and the Arp2/3 complex. Furthermore, the removal of adhesion protein complexes at the ES is mediated, at least in part, by their internalization via endocytic pathways [103, 135, 136] . At the Sertoli cell-elongated spermatid interface, sites of apical ES disassembly just prior to spermiation are occupied by unique structures known as apical tubulobulbar complexes (TBCs), which are tubular invaginations in Sertoli cells arising from protrusions of plasma membrane at the site. Analogous structures defined as basal TBCs also exist at the BTB [132, 133] . Accumulating knowledge supports the hypothesis that TBCs are sites where ES constituent proteins undergo endocytosis [137, 138] . For instance, apical TBCs not only contain components of the endocytic machinery (e.g., dynamin III [139] and clathrin [140] ); they are also enriched by important actin regulators with known functions in branch formation or actin turnover. These include the Arp2/3 complex and its activators, neuronal-WASP (N-WASP) [128, 140] and cortactin [140] , Rac-1 [141] , as well as cofilin [142] . These proteins serve to regulate actin dynamics at TBCs, thereby generating force required for the invagination, scission and release of newly formed endocytic vesicles [143] , which in turn facilitate ES protein internalization. At the BTB, an analogous mechanism is believed to be at play. Taken together, these findings support the emerging view that IL-1a serves as a master regulator of basal ES disassembly by inducing actin remodeling from rigid bundles to a branched network, thereby facilitating protein endocytosis in concert with other cytokines (e.g., TGF-b2, TGF-b3 and TNF-a [135, 144] ) at the BTB. This hypothesis is also consistent with the observation that IL-1a accelerates the kinetics of occludin endocytosis Biology of IL-1 in the testis 495 from the cell surface [13] . Whether IL-1a affects the apical ES in a similar manner remains to be investigated in future. IL-1a also affects junction dynamics by regulating the levels of BTB-constituent proteins. In contrast to TGF-b3 and TNF-a [126, [145] [146] [147] , treatment of Sertoli cells with IL-1a in vitro increased the levels of several BTB constituent proteins, including integral membrane proteins occludin and N-cadherin, and their adaptors ZO-1 and b-catenin [13] . In another study using a Sertoli cell line, IL-1a increased the mRNA level of JAM-B by promoting its transcriptional activation [148] . While it is not known if IL-1a also affects the transcription of occludin and N-cadherin, the increased levels of these proteins were due in part to their accumulation in the cytoplasm after being endocytosed [13] . At this point, we believe that IL-1a initiates BTB disassembly by remodeling the Sertoli cell actin cytoskeleton and that it also encourages BTB assembly by slowing down the degradation of endocytosed structural proteins, which may be needed to assemble the ''new'' BTB below migrating spermatocytes (Fig. 2) . It is worth noting that IL-1a alone cannot initiate BTB assembly because TJs were unable to recover after prolonged IL-1a treatment both in vivo and in vitro [13] . Additional factors are clearly at play. For instance, recycling of endocytosed integral membrane proteins, which may have accumulated in the cytoplasm, back to the cell surface may require the action of testosterone [135] . Therefore, the delicate balance between IL-1a and other paracrine factors and hormones (e.g., testosterone, estrogen) throughout stages VIII to XI is likely to be critical for inducing the disassembly of the ''old'' BTB above spermatocytes in transit concurrent to the assembly of the ''new'' BTB underneath.
Concluding remarks
While IL-1a is an autocrine and/or paracrine factor involved in normal tissue homeostasis, knockout animals displayed normal development and fertility [149] . In addition, our knowledge of IL-1 remains incomplete as most studies were performed on cells treated with recombinant mature proteins. As such, the contribution of proIL-1a signaling in mediating cytoskeletal and cell junctional remodeling remains virtually unexplored. For this reason, future studies are warranted to better understand the regulatory pathway of IL-1a maturation, the differential fate and activity of precursor and mature IL-1a, as well as the identities of proteins mediating alternative IL-1 signaling.
